• December 2023 – Eur Urol Oncology highlights

  • Jan 9 2024
  • Length: 58 mins
  • Podcast
December 2023 – Eur Urol Oncology highlights cover art

December 2023 – Eur Urol Oncology highlights

  • Summary

  • The long-awaited inaugural episode of the European Urology Oncology (EUO) podcast is here! Host, Dr Renu Eapen (Melbourne) highlights two key papers from the December issue of the journal (details below). Tune in for interviews with key authors and local experts. The regular EUO BIO segment highlights other key papers, upcoming meetings, and current affairs in GU oncology. This episode’s EUO BIO features new Editor-in-Chief, Professor Morgan Roupret.

    Available as a classic audio podcast in all the usual places: (insert buzzsprout link)

    Priority papers:

    1. Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer https://euoncology.europeanurology.com/article/S2588-9311(23)00203-1/fulltext

    Featured authors – Professor Peter Albers & Dr Agne Krilaviciute (Heidelberg, Germany)

    2. Oncological Outcomes for Patients with European Association of Urology Very High-Risk Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin or Early Radical Cystectomy https://euoncology.europeanurology.com/article/S2588-9311(23)00157-8/fulltext

    Featured authors – Professor Ashish Kamat (Houston) & Dr Roberto Contieri (Milan)
    Discussant – Professor Nathan Lawrentschuk (Melbourne)

    Full index to European Urology Oncology December 2023 issue https://euoncology.europeanurology.com/current

    Show More Show Less

What listeners say about December 2023 – Eur Urol Oncology highlights

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.